Skip to main content

Glaucoma and cannabis in Nevada

The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Listed qualifying condition
✓ Yes
LEGAL
Up to 2.5 oz over 14-da…
POSSESSION
$50/yr
STATE FEE
5–21 d
TIMELINE
Listed qualifying condition. The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Nevada statute and program

The Nevada Medical Marijuana Program is the operating authority for Nevada patient certification. The authoritative legal text is: Nev. Rev. Stat. Chapter 678A-678D: Cannabis.

What the evidence says about cannabis and Glaucoma

Glaucoma is a group of eye diseases that damage the optic nerve. The most common form, primary open-angle glaucoma, is typically associated with elevated intraocular pressure (IOP), though some patients develop optic-nerve damage at normal IOP. Untreated, glaucoma causes irreversible vision loss. Standard treatment lowers IOP via topical eye drops, laser procedures, or surgery.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Glaucoma page.

How to qualify in Nevada

The Nevada Medical Marijuana Program requires the following registration steps for a Glaucoma patient (or any qualifying diagnosis):

  1. Get a written certification from a Nevada-licensed physician. Under NRS Ch. 678C (the Nevada Medical Marijuana Act, voters approved 2000 and modernized 2021), any Nevada-licensed physician (MD or DO), advanced practice registered nurse, or homeopathic physician may certify a patient. Qualifying chronic or debilitating medical conditions include cancer, glaucoma, HIV/AIDS, anxiety, autism spectrum, autoimmune diseases, dependence on prescription opioids, PTSD, severe nausea, severe pain, seizures, severe muscle spasms, and any condition that is chronic or debilitating per the practitioner’s judgment.
  2. Apply through the Nevada Cannabis Compliance Board portal. The patient creates an account in the Nevada Cannabis Compliance Board (CCB) patient registry portal, uploads the physician written certification, a Nevada driver license or state ID, and a passport-style photograph. Out-of-state patients with a valid medical card from a qualifying state may use the Nevada reciprocity provision without separate registration.
  3. Pay the $50 state registration fee. The two-year Nevada medical marijuana patient registry card fee is $50 (reduced from $75 + $25 background check under 2021 reforms). The fee includes the state background check. Caregivers register at $50 with a separate background check, but caregivers are not required for adult patients.
  4. Receive the card and purchase from a Nevada dispensary. Nevada medical marijuana patient registry cards are typically issued within 14 business days. Patients may purchase up to 2.5 ounces every 14 days from licensed dispensaries and may cultivate up to 12 plants if living over 25 miles from the nearest dispensary. Adult-use retail is legal under Question 2 of 2016; medical patients retain a lower medical tax versus the adult-use tax stack. Nevada honors out-of-state medical cards at Nevada dispensaries.
State registration fee
$50
Physician visit (typical)
$150–$300
Certification to card
5–21 days
Out-of-state patients
Eligible
Minors
Eligible with caregiver

For full Nevada registration steps, fees, and reciprocity rules, see the Nevada cannabis-laws page.

ICD-10 code

A certifying physician documenting Glaucoma for the Nevada medical cannabis program will typically record ICD-10 H40.9 or SNOMED-CT 23986001 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Nevada list Glaucoma as a qualifying condition for medical cannabis?

Yes. Nevada explicitly lists Glaucoma as a qualifying condition under Nevada Medical Marijuana Program. A patient with a documented Glaucoma diagnosis can pursue state-program certification with a physician registered in the state. The qualifying-condition list is set by state statute or regulation and may change. Inclusion on the list does not guarantee certification — a physician still has to evaluate the patient and decide that medical cannabis is appropriate for that specific case under Nevada rules.

How do I get a Nevada medical marijuana card for Glaucoma?

Step one is finding a physician licensed in Nevada who is registered with Nevada Medical Marijuana Program and willing to evaluate Glaucoma cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Nevada honors out-of-state medical cards under its reciprocity rules — uncommon, and worth verifying before relying on it. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Glaucoma?

For Glaucoma, evidence is described as insufficient (no high-quality controlled data is available either for or against). The mmjnow condition page for Glaucoma lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Glaucoma should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Glaucoma and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Glaucoma; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Nev. Rev. Stat. Chapter 678A-678D: Cannabisaccessed May 16, 2026
  2. Cannabis Compliance Board: Nevadaaccessed May 16, 2026
  3. Wikipedia: Cannabis in Nevadaaccessed May 16, 2026
  4. Nev. Rev. Stat. §678D.200: Public consumption prohibitedaccessed May 18, 2026
  5. Cannabis Compliance Board: Consumption Lounge Licensingaccessed May 18, 2026
  6. TSA: What Can I Bring? — Marijuanaaccessed May 18, 2026
  7. Nevada Legislature bill trackeraccessed May 18, 2026
  8. NORML: Nevada Laws & Penaltiesaccessed May 18, 2026
  9. National Academies of Sciences, Engineering, and Medicine (2017): The Health Effects of Cannabis and Cannabinoidsaccessed May 18, 2026
  10. American Academy of Ophthalmology: Marijuana in the Treatment of Glaucomaaccessed May 15, 2026
  11. NIH NCCIH: Cannabis (Marijuana) and Cannabinoidsaccessed May 15, 2026